BioSpace News Archive

Business

Effective April 1, 2018: OraSure CEO to Retire, New Leader Named

The Company also announced updated revenue guidance for the fourth quarter of 2017.

January 4, 2018
·
10 min read
Business

ChemDiv, DZNE and Torrey Pines Investment Launch Inflammasome Discovery Program of Translational Collaboration on Neurodegeneration

The overall goal of the collaboration is to leverage DZNE’s advanced research capabilities with ChemDiv’s commercial expertise to efficiently design and validate new therapeutic candidates for treatment of Alzheimer’s and other neurodegenerative diseases.

January 4, 2018
·
3 min read
Business

AvantGen and Tanabe Research Laboratories Expand Collaboration for Therapeutic Antibody Discovery

Under the terms of the collaboration, AvantGen is responsible for generating novel antibodies to specified cancer targets using its proprietary human antibody yeast display technology platform.

January 4, 2018
·
3 min read
Drug Development

Asterias Biotherapeutics Reports Milestone Targets for 2018

These achievements, combined with the Company’s financial resources position Asterias to achieve the following milestones during 2018.

January 4, 2018
·
6 min read
Policy

Alimera Sciences Receives Acceptance of Filing to Obtain Approval for ILUVIEN Non-Infectious Posterior Uveitis Indication in Europe

Alimera submitted the results from two, randomized, double-masked, multi-center phase 3 clinical trials.

January 4, 2018
·
6 min read
Oculis Raises CHF20 Million in a Series B Financing Round to Advance Breakthrough Treatments for Ophthalmic Diseases

The financing was led by a syndicate of leading international life science investors including Bay City Capital, Novartis Venture Fund and Pivotal bioVenture Partners.

January 4, 2018
·
3 min read
Pharm Country

Feinstein Institute Researcher Awarded $1.2M to Continue Sepsis Research

Feinstein Institute for Medical Research Professor Haichao Wang, PhD, received a $1.2M grant from the NIH NIGMS to continue his search to identify different proteins associated with sepsis, which could lead to a targeted treatment for the condition.

January 4, 2018
·
2 min read
Business

MacroGenics Nabs $380M Pact With Drug Giant Roche

In the deal, both companies will leverage their respective platforms, including MacroGenics’ DART platform and Roche’s CrossMAb and DutaFab technologies to select a bispecific format and lead product candidate.

January 4, 2018
·
3 min read
Drug Development

Ultragenyx Announces Update to UX007 Development Program in Long-Chain Fatty Acid Oxidation Disorder Patients

The company expects that a decision on a potential filing for approval based on Phase 2 data will be made in mid-2018.

January 4, 2018
·
7 min read
Pharming Announces Further Conversion of its Ordinary Convertible Bonds

The newly issued shares represent 4.6% of the outstanding share capital immediately prior to the issue.

January 4, 2018
·
5 min read